We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) Cisplatin 1mg/mL (100mg/100mL) concentrate for solution for infusion (Accord, UK)
Section 19A approved medicine
(Approval lapsed) Cisplatin 1mg/mL (100mg/100mL) concentrate for solution for infusion (Accord, UK)
Section 19A approval holder
Accord Healthcare Pty Ltd ABN 49 110 502 513
Phone
1800 222 673
Approved until
Status
Expired
Medicines in short supply/unavailable
CISPLATIN ACCORD cisplatin 50 mg/50 mL concentrated injection vial - ARTG 286786
CISPLATIN ACCORD cisplatin 100 mg/100 mL concentrated injection vial - ARTG 286791
CISPLATIN ACCORD cisplatin 100 mg/100 mL concentrated injection vial - ARTG 286791
Indication(s)
Cisplatin may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:
- Metastatic non-seminomatous germ cell carcinoma
- Advanced stage, refractory ovarian carcinoma
- Advanced stage, refractory bladder carcinoma
- Refractory squamous cell carcinoma of the head and neck
Images